Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer

NCT03677076 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT03677076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03677076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
Lead sponsor
Medical University of South Carolina
Phase
Observational
Overall status
Completed
Start date
March 4, 2019
Completion date
December 31, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer